MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

Hepatology

Volumn 49, Issue 4, 2009, Pages 1194-1202

  Li, Shuai ^a   Fu, Hanjiang ^a   Wang, Yulan ^b   Tie, Yi ^a   Xing, Ruiyun ^a   Zhu, Jie ^a   Sun, Zhixian ^a   Wei, Lixin ^b   Zheng, Xiaofei ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 101; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN V FOS; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FOSB PROTEIN, HUMAN; MESSENGER RNA; MIRN101 MICRORNA, HUMAN; PROTEIN C FOS;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; MIGRATION INHIBITION; PRIORITY JOURNAL; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; WESTERN BLOTTING; CELL MOTION; DNA SEQUENCE; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; ONCOGENE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; GENES, REPORTER; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 65449170725     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22757     Document Type: Article

References (43)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29; 870-873.
2. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350: 1142-1143.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
4. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576.
5. Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming D, et al. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Cancer Res 2004;64:6058-6064.
6. Wurmbach E, Chen Y, Khitrov G, Zhang W, Roayaie S, Schwartz M, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. HEPATOLOGY2007;45:938-947.
7. Lee JS, Thorgeirsson SS. Comparative and integrative functional genomics of HCC. Oncogene 2006;25:3801-3809.
8. Lemmer ER, Friedman SL, Llovet JM. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: The potential of gene expression profiling. Semin Liver Dis 2006;26:373-383.
9. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
10. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122:6-7.
11. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005;65:3509-3512.
12. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435: 834-838.
13. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-2261.
14. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64: 3753-3756.
15. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-647.
16. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-15529.
17. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005;102:13944-13949.
18. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-843.
19. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, et al. Down-regulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006;99:671-678.
20. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-2545.
21. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-658.
22. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, et al. MicroRNA Profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. HEPATOLOGY2008;47:1955-1963.
23. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. HEPATOLOGY2008;47:1223-1232.
24. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198.
25. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-7070.
26. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006;5:24.
27. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 2007; 210:370-377.
28. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003;115:787-798.
29. Hill CS, Wynne J, Treisman R. Serum-regulated transcription by serum response factor (SRF): A novel role for the DNA binding domain. EMBO J 1994;13:5421-5432.
30. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005;433:769-773.
31. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005;122:553-563.
32. Zamore PD, Haley B. Ribo-gnome: The big world of small RNAs. Science 2005;309:1519-1524.
33. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
34. Fabregat I, de Juan C, Nakamura T, Benito M. Growth stimulation of rat fetal hepatocytes in response to hepatocyte growth factor: Modulation of c-myc and c-fos expression. Biochem Biophys Res Commun 1992;189: 684-690.
35. Rahmani M, Nadori F, Durand-Schneider AM, Lardeux B, Bernuau D. Hepatocyte growth factor activates the AP-1 complex: A comparison between normal and transformed rat hepatocytes. J Hepatol 1999;30:916-925.
36. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101: 2999-3004.
37. Arbuthnot P, Kew M, Fitschen W. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas. Anticancer Res 1991;11:921-924.
38. Wang Z, Xiang Q, Li D, Li S. Correlation between gene expression and chromatin conformation of c-fos and N-ras in human liver and hepatoma. Chin Med Sci J 1991;6:6-8.
39. Feng DY, Zheng H, Tan Y, Cheng RX. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. World J Gastroenterol 2001;7: 33-36.
40. Yuen MF, Wu PC, Lai VC, Lau JY, Lai CL. Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma. Cancer 2001;91:106-112.
41. Reichmann E, Schwarz H, Deiner EM, Leitner I, Eilers M, Berger J, et al. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 1992;71: 1103-1116.
42. Fialka I, Schwarz H, Reichmann E, Oft M, Busslinger M, Beug H. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J Cell Biol 1996;132:1115-1132.
43. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, et al. c-fos is required for malignant progression of skin tumors. Cell 1995;82: 721-732.